Ekkerhard Haen

6PUBLICATIONS
31CO-AUTHORS
PharmacogenomicsMolecular medicinePharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

|May 09, 2025
Nifedipine May Be an Inhibitor of Clozapine Metabolism as Seen in 5 Patients: 2 From a US Double-Blind Study and 3 From a German Therapeutic Drug Monitoring Study.

Georgios Schoretsanitis, Ekkehard Haen, Hélène Verdoux

|Dec 17, 2021
Effects of body weight, smoking status, and sex on plasma concentrations of once-monthly paliperidone palmitate.

Georgios Schoretsanitis, Ekkehard Haen, Daria Piacentino

|Aug 09, 2020
Lack of Smoking Effects on Pharmacokinetics of Oral Paliperidone-analysis of a Naturalistic Therapeutic Drug Monitoring Sample.

Georgios Schoretsanitis, Ekkehard Haen, Andreas Conca

|Jan 21, 2020
Plasma Risperidone-related Measures in Children and Adolescents with Oppositional Defiant/Conduct Disorders.

Daria Piacentino, Georgios D Kotzalidis, Georgios Schoretsanitis

|Mar 02, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians.

Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker

Pageof 1

Frequent Collaborators

6 joint publications

Georgios Schoretsanitis

5 joint publications

Michael Paulzen

3 joint publications

Andreas Conca

3 joint publications

Christoph Hiemke